SOX9 promotes nasopharyngeal carcinoma cell proliferation, migration and invasion through BMP2 and mTOR signaling

SRY-related high-mobility-group box 9 (SOX9) is a member of the SOX family of transcription factors. Accumulating evidence has shown that SOX9 plays a significant role in various malignancies. However, the role of SOX9 in nasopharyngeal carcinoma (NPC) remains unknown. In the present study, up-regul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene 2019-10, Vol.715, p.144017-144017, Article 144017
Hauptverfasser: Xiao, Bin, Zhang, Weiyun, Kuang, Zhenzhan, Lu, Jingrun, Li, Weiwei, Deng, Chun, He, Yongyin, Lei, Ting, Hao, Wenbo, Sun, Zhaohui, Li, Linhai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:SRY-related high-mobility-group box 9 (SOX9) is a member of the SOX family of transcription factors. Accumulating evidence has shown that SOX9 plays a significant role in various malignancies. However, the role of SOX9 in nasopharyngeal carcinoma (NPC) remains unknown. In the present study, up-regulation of SOX9 was observed in both NPC tissues and different NPC cells. Overexpression of SOX9 promoted NPC cell proliferation, migration and invasion. Conversely, knock down of SOX9 inhibited NPC proliferation, colony formation, migration and invasion. Mechanistically, SOX9 bound directly to the promoter region of BMP2 and increased BMP2 expression. In addition, overexpression of SOX9 activated the mTOR pathway partly through BMP2. Collectively, these results identify a novel role for SOX9 as a potential therapeutic marker for the prevention and treatment of NPC. •The expression of SOX9 was elevated in NPC tissues, especially in stage IV NPC tissues.•Overexpression of SOX9 could promote the proliferation, migration and invasion of NPC cells.•SOX could activate mTOR pathway partly though regulating BMP2 expression.
ISSN:0378-1119
1879-0038
DOI:10.1016/j.gene.2019.144017